GlaxoSmithKline plc and Vir Biotechnology, Inc. announced the US Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for sotrovimab (previously VIR-7831), an ...
As the omicron variant completes its sweep across the U.S., states with scarce supplies of monoclonal antibody therapies continue to use two treatments that federal health officials warn no longer ...
The acquisition of mutations conferring a high level of resistance to sotrovimab and the dynamics of the viral load of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are shown. Panel A ...
The unprecedented COVID-19 pandemic has claimed more than 5 million lives globally since it emerged in Wuhan, China, in late December 2019. The causative agent, severe acute respiratory syndrome ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback